MedsFacts.com




MedsFacts Meta-Analysis covering adverse side effect reports of LIPITOR patients who developed WHOLE BLOOD TRANSFUSION.



Introduction: MedsFacts provides MD-approved analysis to help both patients and physicians accurately research and assess the risk-reward trade off for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration, social media, and MedsFacts user submissions. Between January 2004 and October 2012, 6 individuals taking LIPITOR reported WHOLE BLOOD TRANSFUSION to the FDA. A total of 102441 LIPITOR drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

Topics covered: This page is designed to help you determine the relationship, if any, between LIPITOR and WHOLE BLOOD TRANSFUSION. In doing so, we compare LIPITOR with other drugs that cause WHOLE BLOOD TRANSFUSION, to help you evaluate whether or not LIPITOR causes WHOLE BLOOD TRANSFUSION. Likewise, this page shows the most highly-reported side effects of LIPITOR, so you can see if WHOLE BLOOD TRANSFUSION ranks among LIPITOR's most well-known side effects.

The Dashboard explained: The Dashboard first shows general Summary Statistics for LIPITOR and WHOLE BLOOD TRANSFUSION, such as the raw number and percentage of patients in FDA reports who used LIPITOR and developed WHOLE BLOOD TRANSFUSION. Next, the Dashboard lists the most common reasons (indications) why LIPITOR was prescribed for patients. We then display a pie-chart which shows, in aggregate, what we believe represents general physician opinion of the safety of LIPITOR. This pie-chart summarizes, for all FDA reports covering LIPITOR, whether or not the treating physician felt LIPITOR (versus other drugs the patient was taking) was responsible for the adverse side-effects. After the pie-chart, we itemize the most common side effects in FDA studies covering LIPITOR. You may click on any of these side effects to learn more about them, in general, or specifically for LIPITOR. Finally, we identify the drugs most widely associated with LIPITOR in FDA literature. You may also click on any of these drugs to view it's dashboard.

Dashboard view of our research literature concerning LIPITOR :

Summary Statistics
Reports of WHOLE BLOOD TRANSFUSION in patients taking LIPITOR: 6
Reports of any side effect developing while on LIPITOR : 102441
Percentage of LIPITOR patients where WHOLE BLOOD TRANSFUSION is a reported side effect: 0.0058570299001376%

FDA reports of any drug causing WHOLE BLOOD TRANSFUSION : 63
Average percentage for all medicated patients where WHOLE BLOOD TRANSFUSION is reported as a complication: 0.00039484681040553%


Physician opinion on LIPITOR as adverse event culprit:

(* global)
Most frequent diagnoses/indications for prescribing LIPITOR:
BLOOD CHOLESTEROL INCREASED ( 14589 patients )
HYPERCHOLESTEROLAEMIA ( 3964 patients )
HYPERLIPIDAEMIA ( 3904 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 3056 patients )
BLOOD CHOLESTEROL ( 2732 patients )
DRUG USE FOR UNKNOWN INDICATION ( 2270 patients )
ILL-DEFINED DISORDER ( 1560 patients )
DYSLIPIDAEMIA ( 1138 patients )
BLOOD CHOLESTEROL ABNORMAL ( 862 patients )
BLOOD TRIGLYCERIDES INCREASED ( 376 patients )
CARDIAC DISORDER ( 319 patients )
MYOCARDIAL INFARCTION ( 279 patients )
LOW DENSITY LIPOPROTEIN INCREASED ( 272 patients )
CORONARY ARTERY DISEASE ( 246 patients )
HYPERTENSION ( 245 patients )
PROPHYLAXIS ( 200 patients )
LIPIDS INCREASED ( 169 patients )
HYPERTRIGLYCERIDAEMIA ( 154 patients )
CEREBROVASCULAR ACCIDENT ( 144 patients )
TYPE IIA HYPERLIPIDAEMIA ( 117 patients )
LIPIDS ABNORMAL ( 70 patients )
HIGH DENSITY LIPOPROTEIN DECREASED ( 67 patients )
BLOOD TRIGLYCERIDES ( 66 patients )
DIABETES MELLITUS ( 63 patients )
ARTERIAL OCCLUSIVE DISEASE ( 49 patients )
CARDIOVASCULAR EVENT PROPHYLAXIS ( 47 patients )
CARDIOVASCULAR DISORDER ( 46 patients )
STENT PLACEMENT ( 45 patients )
ARTERIOSCLEROSIS ( 45 patients )
CARDIAC OPERATION ( 40 patients )
CORONARY ARTERY BYPASS ( 39 patients )
BLOOD PRESSURE ( 37 patients )
VASCULAR GRAFT ( 35 patients )
METABOLIC DISORDER ( 35 patients )
LIPID METABOLISM DISORDER ( 34 patients )
BLOOD TRIGLYCERIDES ABNORMAL ( 34 patients )
CORONARY ARTERY OCCLUSION ( 33 patients )
TRANSIENT ISCHAEMIC ATTACK ( 33 patients )
CEREBROVASCULAR ACCIDENT PROPHYLAXIS ( 31 patients )
MYOCARDIAL ISCHAEMIA ( 31 patients )
LIPIDS ( 29 patients )
ACUTE MYOCARDIAL INFARCTION ( 27 patients )
BLOOD CHOLESTEROL DECREASED ( 27 patients )
ACUTE CORONARY SYNDROME ( 24 patients )
CORONARY ARTERIAL STENT INSERTION ( 24 patients )
ANGINA PECTORIS ( 24 patients )
ISCHAEMIC HEART DISEASE PROPHYLAXIS ( 23 patients )
LOW DENSITY LIPOPROTEIN ( 22 patients )
TYPE 2 DIABETES MELLITUS ( 22 patients )
LOW DENSITY LIPOPROTEIN ABNORMAL ( 19 patients )
CARDIAC FAILURE CONGESTIVE ( 19 patients )
FAMILIAL RISK FACTOR ( 16 patients )
METABOLIC SYNDROME ( 15 patients )
INFARCTION ( 15 patients )
BLOOD PRESSURE ABNORMAL ( 14 patients )
ARTERIAL DISORDER ( 12 patients )
ANGINA UNSTABLE ( 12 patients )
ARTERIOSCLEROSIS CORONARY ARTERY ( 11 patients )
ATRIAL FIBRILLATION ( 11 patients )
CATHETERISATION CARDIAC ( 11 patients )
BLOOD PRESSURE INCREASED ( 10 patients )
CEREBROVASCULAR DISORDER ( 9 patients )
CHRONIC OBSTRUCTIVE PULMONARY DISEASE ( 9 patients )
CARDIAC FAILURE ( 9 patients )
HEPATIC STEATOSIS ( 9 patients )
CAROTID ARTERY OCCLUSION ( 8 patients )
MYALGIA ( 8 patients )
CAROTID ARTERIOSCLEROSIS ( 8 patients )
CAROTID ARTERY STENOSIS ( 8 patients )


Basic reports are available, free of charge, in PDF format and are suitable for scientific publication. Further data and analytics are available upon request. We are in the process of adding new features to our site, including Q&A interface for patients to speak with experts on medication. Check back with us again in the near future to see.





Copyright 2013 MedsFacts
info@medsfacts.com
Privacy Policy
Terms of use